Logo ofMorabaha Marina Financing Co. (MRNA)
The Saudi Exchange (Tadawul) announced placing a trading halt on shares of Morabaha Marina Financing Co. (MRNA) for one trading session on May 18. 
For more news on listed companies
The trading suspension was driven by MRNA’s noncompliance as regards disclosing its financial statements for the period ended March 31, 2025, during the specified period mentioned in the Rules on the Offer of Securities and Continuing Obligations.
MRNA shares will resume trading for twenty trading sessions starting from Monday, May 19, and the company is required to announce its financial statements before end of Thursday, June 19.
In the event that MRNA did not disclose its financial statements for the period ended March 31, 2025, a trading halt would be placed on the stock as of June 22, until the company discloses its financial statements.
MRNA stated that it would not be able to release its preliminary financial results for the three-month period ended March 31, 2025, within the statutory deadline.
The delay is due to the change from its former external auditor to PricewaterhouseCoopers Professional Services, which hindered the completion of the review process of the financials, data compiled with Argaam showed.
Logo ofMorabaha Marina Financing Co. (MRNA)
The Saudi Exchange (Tadawul) announced placing a trading halt on shares of Morabaha Marina Financing Co. (MRNA) for one trading session on May 18.
For more news on listed companies
The trading suspension was driven by MRNA’s noncompliance as regards disclosing its financial statements for the period ended March 31, 2025, during the specified period mentioned in the Rules on the Offer of Securities and Continuing Obligations.
MRNA shares will resume trading for twenty trading sessions starting from Monday, May 19, and the company is required to announce its financial statements before end of Thursday, June 19.
In the event that MRNA did not disclose its financial statements for the period ended March 31, 2025, a trading halt would be placed on the stock as of June 22, until the company discloses its financial statements.
MRNA stated that it would not be able to release its preliminary financial results for the three-month period ended March 31, 2025, within the statutory deadline.
The delay is due to the change from its former external auditor to PricewaterhouseCoopers Professional Services, which hindered the completion of the review process of the financials, data compiled with Argaam showed.
